Publication | Open Access

A New Curcumin Derivative, HBC, Interferes with the Cell Cycle Progression of Colon Cancer Cells via Antagonization of the Ca2+/Calmodulin Function

Tumor BiologyOncologyChemoprevention StrategyMedicineColon Cancer CellsPharmacologyCa2+/calmodulin FunctionColorectal CancerAnti-cancer AgentTumor SuppressorCancer BiologyCell BiologyCell SignalingCancer ResearchNew Curcumin Derivative